Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Novel in situ vaccination with intratumoral injection of CpG 7909, a TLR 9 agonist, combined with radiation in mycosis fungoides and primary cutaneous B-cell lymphoma 68th Annual Meeting of the Society-for-Investigative-Dermatology Morales, A. V., Hoppe, R., Shah, S., Levy, R., Kim, Y. NATURE PUBLISHING GROUP. 2007: S43–S43
View details for Web of Science ID 000245387800257